SCHEMBL3467256

SCHEMBL3467256

O=C(Nc1ccc(Cl)c(Cl)c1)Nc1nnc(Cc2ccccc2F)s1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.74
KMT2A Q03164 10/20 0.74
RAB9A P51151 3/20 0.67
NPC1 O15118 1/20 0.67
HTT P42858 7/20 0.63
SMN1; SMN2 Q16637 5/20 0.63
LMNA P02545 5/20 0.63
MAPT P10636 5/20 0.63
BLM P54132 3/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
POLB P06746 1/20 0.53
GAA P10253 1/20 0.53
DNMT1 P26358 1/20 0.53
DUSP3 P51452 1/20 0.53
CACNA1B Q00975 1/20 0.53
APBA1 Q02410 1/20 0.53
MCL1 Q07820 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3466713 0.83 MEN1 (0.62) MEN1KMT2ARAB9ANPC1HTT
SCHEMBL3466712 0.83 MEN1 (0.67) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL3467221 0.82 MAPT (0.77) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL3467177 0.82 RAB9A (0.64) MEN1KMT2ARAB9ANPC1HTT
SCHEMBL3467385 0.81 RAB9A (0.69) MEN1KMT2ARAB9ANPC1HTT
SCHEMBL3467090 0.80 MEN1 (0.68) MEN1KMT2ARAB9ANPC1HTT
SCHEMBL3468497 0.79 SMN1; SMN2 (0.70) MEN1KMT2ARAB9ANPC1HTT
SCHEMBL3467467 0.78 MEN1 (0.62) MEN1KMT2ARAB9ANPC1HTT
SCHEMBL3467776 0.78 MEN1 (0.56) MEN1KMT2ARAB9AHTTSMN1; SMN2
SCHEMBL3467231 0.77 SMN1; SMN2 (1.00) MEN1KMT2ARAB9AHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010073011-A2 COMPOUNDS USEFUL AS MEDICAMENTS BETAGENON AB (SE) 2010-07-01 WO claimed
WO-2010073011-A2 COMPOUNDS USEFUL AS MEDICAMENTS BETAGENON AB (SE) 2010-07-01 WO disclosed